Transfusion emergency preparedness is increasingly being recognized as an important element in the healthcare response to mass casualty events (MCE). Planning should be designed to support an integrated response between the blood services and hospitals. The lessons identified from the Manchester Arena bombing in 2017 and recent incidents in London have led to new guidance. Demand planning has been informed by the global experience of civilian MCEs and the changing trends in trauma care. Past evidence suggests that only a modest number of hospitalized patients following MCEs require transfusion. The mean blood use per patient admitted is consistently calculated at 2-3 red cell units. Most blood is used within the first 6 h. However, a small number of critically injured with multi-trauma may require massive transfusion and ongoing support. Many blood services have reported meeting the initial overall demand for blood from stock. However, universal components may be in short supply. The demand can be managed by pre-agreed substitutions. Early transfusion triage enables the best use of hospital laboratory and blood service support. Careful communication with donor communities is essential to manage a controlled replenishment of stocks. Future challenges for the transfusion community include the trend towards lower red cell stock holdings and the changing trends in weapon use and tactics. A standardized approach to transfusion data collection is required to support future planning. The transfusion community is encouraged to plan for MCEs, contribute to 'after action reviews' and work together for safe and sustainable transfusion support.
Introduction
Recent terrorist events remind us again that no nation is immune from the traumatic injuries seen in military medicine and civil war. There have been multiple mass casualty events (MCEs) in the last few years following the use of improvised explosive devices (IEDs), firearms and knives. In addition, vehicles have been used as a 'weapon'. Tactics are changing and appear to be evolving to maximize mortality and political impact [1] . The medical response for such events should be designed to reduce potentially preventable death from trauma. The leading preventable cause of death from trauma is haemorrhage which must be managed early. The care of the individual patient with traumatic haemorrhage is demanding. This is further complicated in the mass casualty situation where both first healthcare response and evacuation may be delayed.
An MCE may be defined as a 'single or simultaneous event(s) or other circumstances where the normal major incident response of one or several health organizations must be augmented by extraordinary measures to maintain an efficient, suitable and sustainable response' [2] . The definition of MCEs implies that critical sufficiency and supply of resources may be locally constrained, one of which is blood. Planned mass gatherings such as sporting and religious events also provide the potential for MCEs and require healthcare planning. Doughty et al. have contended that transfusion emergency preparedness should be an integrated part of the medical planning process [3] . Emergency preparedness should include both emergency planning and business continuity [4] . We suggest that the overall aims of transfusion emergency preparedness for blood providers should be holistic and include the following: (1) To protect the delivery of key products and services. (2) To manage the incident within the constraints of regulatory and legislative requirements. 
Transfusion for Trauma
Recent reviews of MCEs have highlighted once more that only a modest number of hospitalized patients require transfusion following MCEs [2, 5] . However, a small number of critically injured with multi-trauma may require emergency transfusion as part of 'Damage Control Resuscitation' (DCR). DCR is well described and should start in the pre-hospital environment [6] . The pre-hospital management of major haemorrhage focuses primarily on the timely prevention of further blood loss. Active violent incidents, where there is an ongoing danger to emergency staff, may delay access to medical first responders. In the United Kingdom, the Citizen Aid initiative aims to prepare the public to deliver essential first aid until professional help is available. Haemorrhage control is led through compression of active bleeding, topical haemostats, the use of tourniquets and application of pelvic binders where appropriate. In addition, pre-hospital care should be designed to mitigate the development of Trauma Induced Coagulopathy (TIC) [7] by the active management of hypothermia and hypoperfusion. TIC is the acute intrinsic coagulopathy arising in severely injured trauma patients and is an emergent property of tissue injury combined with hypoperfusion. Brohi et al. 2003 have demonstrated that approximately, one-third of all patients admitted with severe trauma are coagulopathic and that coagulopathy correlates with morbidity and mortality [8] and should be addressed by resuscitation.
Emerging resuscitation practice for traumatic haemorrhage advocates early use of blood, including whole blood [9] . Shock should be reversed as soon as possible and ideally not delayed longer than 30 min [10] . The aim is to deliver a casualty to definitive healthcare with sufficient physiological reserve. The chaotic context of the MCE may prevent the safe use of pre-hospital transfusion; however, blood-based resuscitation should be started as soon as feasible. The use of a plasma first strategy may mitigate some of the risks associated with a red cell-based resuscitation strategy and should be explored. Plasma is increasingly used as pre-thawed plasma however this logistically tethers the pre-hospital provider to the blood bank [11] . Contemporary pre-hospital resuscitation trials predicate the wider availability and use of 'dried' plasma.
The recently published PAMPer trial demonstrated a survival advantage where 2 units of pre-thawed plasma were used before either red cells or crystalloids [12] . However, the smaller COMBAT trial was interrupted for futility shortly before reaching its target enrolment [13] . Naumann et al. suggest this might have been due to the ambitious mortality targets and the short transfer times (20 min) [14] . In contrast, the situation in MCEs may result in much longer pre-hospital holds before transfer to definitive care. Further studies are required.
The aim of in-hospital management should be to provide the best possible care within the resource constraints generated by the surge in casualties [3] . In the United Kingdom, major trauma centres (MTCs) form the focus of the response for the most severely injured casualties. However, all hospitals should be familiar with the management of massive haemorrhage and 'massive' transfusion. The definition of massive transfusion varies but a useful working definition is 5 units of red cells in 4 h [15, 16] . Massive transfusion protocols provide a useful common management framework for both clinical and laboratory staff [17] . The principles for adults and children are similar; however, whereas adult practice is based on units of components, the dosage for transfusion support for children is based on weight [18] . The increasing use of massive haemorrhage protocols has been associated with the use of fixed formula 'Shock packs' or Acute Transfusion Packages [19] . The first pack may be issued as universal components such as group O red cells and group A plasma. This approach permits pre-positioning of emergency stock [20] . However, this may stress the sustainability of supply especially in the context of multiple casualties.
Blood grouping and selection of components
Transfusion triage or prioritization is recommended to support both demand management and patient safety.
The use of blood and the selection of blood components may be determined by treatment priority, patient gender and age. A critical task is blood grouping as the use of group specific components will reduce the demand for universal components. However, the biggest risk of transfusion in this situation is ABO incompatibility. The risk is associated with failures throughout the transfusion process. Sound systems are required for the emergency identification of the unknown patient and sample labelling. Emergency identification should be based on a unique identifier using non-sequential numbering. Baseline patient blood samples should be taken before transfusion to establish the ABO and RhD group. Many countries require two separate samples for this confirmation of blood group. Sampling and testing take time. Emergency blood may be used where clinicians consider this to be essential. The selection of emergency 'universal' components will vary according to blood stocks. Shortages of group O D negative red cells and group AB plasma are common, especially following bad weather and during the holiday seasons. Substitutions may be required. The selection of substitutions should be determined by national guidelines and local policy.
Plasma is increasingly used in trauma. The use of group A plasma is increasingly being used instead of group AB when the patient's blood type is unknown [21] . The Eastern Association for the Surgery of Trauma studied patients receiving incompatible type A [22] . This multi-centre study identified 120 patients, that is 8% of the total 1536 trauma patients, identified as group B and AB who had received 'incompatible 'group A plasma. The authors found no apparent increase in mortality or morbidity in these patients. The preparation of plasma varies but larger centres should consider the pre-thawing of frozen plasma if one or more patients with significant haemorrhage are anticipated. The use of group A plasma combined with an extended post thaw shelf-life of 5 days revolutionized the delivery of transfusion for military trauma [23] . Few patients have required platelets following MCEs. Group A and B platelets are often used as universal components rather than Group O. Testing for haemolysins varies [24] . The introduction of platelet additive solutions may further reduce the risk of haemolysis. Red cell contamination of platelets may be associated with subsequent alloimmunization. Prophylactic anti-D immunoglobulin is recommended where appropriate [25] . ABO compatibility for red cells and whole blood is essential. In addition, further antigen selection such as D and K may be advised to prevent alloimmunization. However, D and K negative red cells may be in short supply and should be prioritized for children and women under the age of 50.
Transfusion demand planning for MCEs
Transfusion demand planning has not traditionally been an important element for major incident planning. However, the literature is developing. The Israeli contribution to the literature in the mid-2000s is considerable and was underpinned by excellent centralized records of blood issues for MCEs. It is worth noting that the Israeli blood service as part of the Magen David Adom receives an early notification following a terrorist attack or any other emergency. The Magen David Adom is Israel's national emergency medical, disaster, ambulance and blood bank service which facilitates a uniquely integrated and timely approach. A past Israeli survey of 1645 attacks involving 7497 casualties suggested 13% death at scene with 8% severe (P1) and 12% (P2) moderate casualties, that is a total of 20% who may need blood. The average red cell use per hospitalized patient was 1Á3 units if all patients are considered and 6Á7 units for the moderate and severely injured [26] . The 2005 London bombings review [27] showed a demand for blood similar to that of UK military casualties, that is 15 units each of red-blood-cells and plasma. [28] However, the pattern has not been seen in more recent events which are characterized by a more modest demand for blood. In 2013, Glasgow and others from the Royal London Hospital published a comprehensive review of blood product use in civilian MCEs [2] . Their review of the literature of 51 civilian MCEs within a 30-year period suggested that the median red cell requirement per admitted casualty was 2-3 units and 6 units for severely injured casualties. The Glasgow paper highlighted inconsistent reporting of blood use following MCEs and recommended the need for standardization. In addition, the authors commented that massive transfusion practice was changing with a greater use of hemostatic components.
Since these papers, there have been numerous incidents across Europe some of which have included detail on transfusion. Trauma response papers have been published following the terrorist attacks in Norway [29] , Boston [30] , Paris and Nice [31] and Brussels [32] . The last two papers provide valuable commentary on managing the donor response. The paper from Norway [29] is useful in that it provides details of blood component requirements for both a bombing and shooting scenario where the patients were treated by the same trauma unit. However, it is difficult to draw conclusions about the impact of the mechanism because the response and evacuation times for each event were very different. The massive transfusion protocol was initiated in 7/149 of the injured cases (4Á7%). The mean blood use in those patients treated with massive transfusions was red-blood-cells 7Á6 units, Octaplas 5Á6 and 2 Adult Therapeutic Doses (pools of 4) of platelets. These recent incidents were included in a review by Ramsey in September 2017 [5] . The careful mathematical treatment of MCEs since 1980 led him to conclude that the average use of components per all admitted patients was 3Á06 units of red cells together with 2Á13 units of plasma and 0Á37 platelet doses. The average demand for components correlated with the number of casualties.
It appears that the simplest method of planning is currently based on 3 units of red cells per casualty admitted to the hospital. Access to whole blood may reduce this. The planning figure includes P1 and P2s grouped together as it is difficult to separate these groups within the pre-hospital environment. The more severely injured may need 6-8 but individual demands vary enormously. The percentage of injured needing blood also varies enormously. Ramsey has calculated the mean as 32% with a range of 7-48%. This contrasts with earlier reports from Israel where it was nearer 20% [26] . The use of uncrossmatched red cells varies greatly with a mean of 22% and a range of 3-41%. We note that both the numbers transfused and the units per patient admitted (UPA) have increased over time. It is uncertain whether this reflects the changes in clinical practice, availability of blood or changes in threat. The Westminster attack is an example of a single individual using a variety of methods. On 22 March 2017 at 14Á40, an attacker drove a car along a pavement on Westminster Bridge in London, stabbed an unarmed policeman and was shot dead by police. Five people died. Initial police reports suggested that at least 50 people were injured, with approximately 30 requiring hospital treatment [23] . Orders were placed for group O red cells, group A plasma and platelets from three hospitals ( Table 1 ). The amount of blood ordered was modest. The main challenges for the blood service were bringing forward the validation of newly collected platelets and the emergency delivery to hospitals in 'Lock down'.
In addition to the revised planning figures, we also recommend a demand factor when calculating demand and stock figures. Authors have reported that hospitals may demand more blood then immediately required. The red cell demand factor may be x2 [33, 34] or x3 [27] . However, the demand factor may differ within blood groups. Following the Manchester bombing, the total order from the blood service associated with the incident was: 334 red cells (SAGM); 58 FFP, 18 packs of platelets; and 12 pools of methylene blue treated cryoprecipitate. Records suggest that twenty-three patients were transfused a total of 89 units. Although this gives a mean RBC use of 3Á9 units, the mode was 2. It should be noted that this MCE was characterized by a higher demand ratio of 3Á75 [20] and that the demand ratio for group O D negative red cells was 5Á3. The latter may have been related to an event involving many young women.
Blood donation and stock management
The transfusion system extends from vein to vein. The immediate demand for blood should be met by existing stocks even if this requires stock movement. However, replacement will normally be required. Blood donor organizations and providers should work closely with blood donors to ensure a safe and sustainable supply of blood. Most services aim to hold sufficient stocks rather than to accept emergency donations. However, others may choose to use alternative models of preparedness using emergency donor panels and whole blood [3] . The challenges of donor management following MCEs are a recurrent theme. One of the responses of the public is to offer to immediately donate blood irrespective of the requirements. In 2002, Schmidt summarized the US experience following the attacks on the World Trade centre and the Pentagon on 11 September 2001. Following these concurrent incidents, 475 000 units of blood were collected, but only 258 units were used [35] . More recently colleagues have described the surge in donor attendance [31, 32] . The recent 2017 bombing in Manchester Arena, United Kingdom led to a surge in donor activity which stressed the blood service Information Technology capacity. Active internal and external communication is required to manage the response. The challenge for blood services is how to harness long term, that spirit of public altruism that manifests immediately after a disaster.
Blood services will need their own mechanisms to manage both the demand resulting from an MCE and the replenishment of stock following the incident. Replenishment may use a variety of approaches including: (1) Stock movements (2) Use of emergency or high readiness donors (3) Increase in collection targets Planned or predicted events permit proactive planning including a stock build or redistribution. However, resilience for MCEs and blood shortages is increasingly challenged by the reduced stock holdings as many blood services respond to the decreasing demand for red cells. The demand for red cells has fallen due to the success of the patient blood management [36] movement. The decisions made to meet routine business requirements may impact on resilience and the ability to surge. The sustained reduction in red cell demand may logically lead to restructuring with reduced capacity for collections, processing, testing or other requisites of the supply chain. The impact on the emergency response can be in part mitigated by an agile logistics response. However, capacity may need to be retained to enable planned escalation throughout the supply chain if alternative approaches are insufficient. Whereas, the immediate aim is to reduce the impact of the MCE, the organization must prepare for recovery and prevent subsequent stock shortage.
Future directions
Many established centralized services assume that all immediate demands will come from existing hospital and blood service stocks. However, these assumptions may not hold for isolated communities. Emergency donor panels may be used as part of the resilience plan [3, 37] . Stock holdings and resilience plans are based on risks, routine workload and logistics especially where blood needs to be redistributed. The balance between demand and supply often straddles organizational boundaries. Partnership within the whole transfusion system is essential. Communication is key but pre-agreed plans are essential. In the United Kingdom, there have been generic shortage plans for both red cells and platelets since 2009. The plans are designed to prioritize the use of blood in the context of blood shortage for any reason. The plans are underpinned by the principles of patient blood management and are regularly updated [38, 39] . Guidance for MCEs was issued to hospital blood banks following the 2005 London bombings [27] . This was the largest UK MCE in recent times with 56 fatalities and over 700 people injured. The lessons identified for the blood service and hospitals were addressed in articles [40] following a set of recommendations from a short-lived working group of the UK National Blood Transfusion Committee (NBTC). The NBTC regularly reviews policy and guidelines for best transfusion practice and ensures distribution of guidance to hospitals [41] . Since then, all Clinical Laboratory Services should have a Major Incident plan with clear guidance for maintaining essential services in addition to responding to the incident.
Recently, the NBTC has reconvened the Emergency Planning working group to update the recommendations. Future guidance will advise the use of pre-determined casualty dispersal plans to estimate patient numbers. Blood demand per patient admitted is based on injury severity. New recommendations reflect changes in laboratory practice such as the pre-thawing of frozen plasma. Staff management continues to be emphasized. The early work following an MCE is often physically and emotionally intense [42] . Additional staff may be required especially out of core hours however, careful organization of staff is essential if the effort is to be sustained and safe [43] . Whereas before, hospital laboratories were advised to re-call issued but non-essential units from remote fridges to centralize stock, the move now is to pre-position blood components and transfusion staff in the Emergency Department and theatres [20] . Staff can be used to support the optimal use of blood components and the management of blood samples. The correct collection and labelling of blood samples using emergency identification is crucial for patient safety [44] . Experience in Manchester and London have demonstrated the value of the transfusion team in the clinical space.
Transfusion practice and planning in MCEs is changing. Roles and responsibilities are being redefined. Transfusion is being increasingly integrated into wider healthcare emergency planning. Plans should be rehearsed. NHSBT has supported table-top exercises at local, regional and national levels. Such exercises have challenged existing assumptions and logistic plans. Preparedness should be a dynamic process and change is inevitable. The planning assumptions described in this article are based on the past and do not predict the future. For example, military blood use increased after 2009 following changes in both the threat and transfusion practice [28, 45] . The trends in civilian use are harder to analyse as response times and resources vary for each event. However, the reviews by Shinar in 2006, Glasgow in 2013 and Ramsey in 2017 suggest that the number of blood components used per patient has increased. Ramsey suggests that the requirements are greater in the context of IEDs rather than shootings. However, planning may need to be revised once more information following recent events is shared. Callaway highlights that there are challenges and gaps in the trauma response to high threat MCEs. He contends that it is difficult to advocate for modern clinical care practices without further civilian injury and mortality data [1] . We recommend that a transfusion data set is required and that we all have a responsibility to contribute to the transfusion 'after action review'.
Conclusions
Recent terrorist incidents have resulted in multiple casualties. The proportion requiring transfusion has been variable and the units per patient admitted was modest. However, some patients have required complex transfusion-based resuscitation. The demand for blood has been met by existing supplies however there have been challenges especially for the supply of universal components. Transfusion emergency preparedness is required to provide a timely, safe and sustainable supply of blood. The whole transfusion community is encouraged to plan for MCEs, share their operational experience and work in partnership for mutual support.
